baby powder

Photo
06.04.2023 • News

Plaintiffs Reject newest J&J Talc Litigation Offer

Seeking to clear billions of dollars worth of litigation claiming that its iconic baby powder causes cancer, Johnson & Johnson has announced it is now prepared to offer a payout of $8.9 billion over 25 years to resolve all claims.

Photo
02.02.2023 • News

US Court Rules against J&J Bankruptcy Scheme

A US federal appeals court panel has unanimously dismissed an attempt by Johnson & Johnson to use a controversial procedure that could resolve claims from lawsuits claiming the healthcare group’s talc-based baby powder caused their cancer.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.